VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AGL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AGLAgilon Health, Inc.
$107.47$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAGLQuarterly Financials

Agilon Health, Inc. (AGL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Agilon Health, Inc. (AGL) quarterly income statement — complete revenue, gross profit & net income history

AGL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.42B1.57B1.44B1.39B1.53B1.52B1.45B1.48B1.6B815.5M1.14B1.07B1.05B689.77M694.86M670.13M653.45M462.89M458.61M498.96M
Revenue Growth %-7.33%3.09%-1.08%-5.92%-4.46%86.69%27.63%38.69%52.17%18.23%63.61%59.54%61.35%49.02%51.51%34.31%58.18%44.2%46.67%-
Cost of Goods Sold01.67B1.5B1.45B1.48B1.56B1.52B1.45B1.53B910.8M1.1B1.01B981.19M679.78M668.95M636.22M610.98M453.3M443.66M476.18M
COGS % of Revenue-106.22%104.71%103.76%96.69%102.51%104.42%97.83%95.32%111.69%96.76%94.9%93.06%98.55%96.27%94.94%93.5%97.93%96.74%95.43%
Gross Profit0-97.64M-67.65M-52.43M50.72M-38.26M-64.17M32.17M75.09M-95.3M36.84M54.58M73.12M10M25.91M33.91M42.46M9.59M14.96M22.78M
Gross Margin %--6.22%-4.71%-3.76%3.31%-2.51%-4.42%2.17%4.68%-11.69%3.24%5.1%6.94%1.45%3.73%5.06%6.5%2.07%3.26%4.57%
Gross Profit Growth %-100%-155.23%-5.42%-262.94%-32.45%59.86%-274.18%-41.05%2.69%-1053.34%42.17%60.92%72.2%4.26%73.24%48.88%45.98%81.42%-41.17%-
Operating Expenses54.23M58.12M63.63M63.6M72.83M69.84M69.34M75.52M82.27M64.31M76.13M83.53M72.71M79.11M55.43M54.97M43.21M57.46M50.56M321.14M
OpEx % of Revenue3.82%3.7%4.43%4.56%4.75%4.59%4.78%5.09%5.13%7.89%6.7%7.81%6.9%11.47%7.98%8.2%6.61%12.41%11.02%64.36%
Selling, General & Admin54.23M60.1M56.2M56.28M65.96M59.76M63.12M69.61M76.42M63.28M72.06M79.25M69.75M75.21M51.98M51.92M39.83M53.84M46.64M317.56M
SG&A % of Revenue3.82%3.83%3.92%4.03%4.3%3.92%4.35%4.69%4.76%7.76%6.34%7.41%6.62%10.9%7.48%7.75%6.1%11.63%10.17%63.65%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses0-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income4M-155.76M-131.27M-116.03M-22.11M-108.1M-133.51M-43.34M-7.18M-159.6M-39.29M-28.96M417K-69.12M-29.52M-21.05M-743K-47.87M-35.6M-298.36M
Operating Margin %0.28%-9.92%-9.15%-8.32%-1.44%-7.1%-9.2%-2.92%-0.45%-19.57%-3.46%-2.71%0.04%-10.02%-4.25%-3.14%-0.11%-10.34%-7.76%-59.8%
Operating Income Growth %118.08%-44.09%1.67%-167.69%-208.02%32.27%-239.77%-49.68%-1821.34%-130.91%-33.12%-37.55%156.12%-44.38%17.09%92.94%93.87%-20.46%-261.65%-
EBITDA10.78M-148.79M-123.84M-108.71M-15.23M-101.61M-127.29M-37.44M-1.33M-154.46M-33.98M-23.44M4.61M-65.21M-26.07M-18.01M2.63M-44.23M-31.66M-294.75M
EBITDA Margin %0.76%-9.48%-8.63%-7.79%-0.99%-6.67%-8.77%-2.52%-0.08%-18.94%-2.99%-2.19%0.44%-9.45%-3.75%-2.69%0.4%-9.56%-6.9%-59.07%
EBITDA Growth %170.79%-46.44%2.71%-190.38%-1041.98%34.22%-274.56%-59.7%-128.96%-136.85%-30.37%-30.16%75.13%-47.42%17.67%93.89%130.46%-22.91%-399.2%-
D&A (Non-Cash Add-back)6.79M6.97M7.43M7.32M6.88M6.49M6.22M5.91M5.84M5.15M5.31M5.51M4.19M3.91M3.45M3.04M3.37M3.64M3.94M3.61M
EBIT0-185.84M-108.7M-102.74M-177K-103.1M-115.4M-28.55M4.4M-160.78M-19.21M-13.4M9.69M-54.23M-28.94M-19.51M1.53M-56.41M-35.87M-295.4M
Net Interest Income1.81M-1.72M-1.84M-1.57M-1.51M-1.57M-1.62M-1.7M-1.28M-1.89M-1.62M-1.55M-1.49M-1.71M-1M-945K-871K-840K-867K-1.5M
Interest Income00000000000000000000
Interest Expense-1.81M1.72M1.84M1.57M1.51M1.57M1.62M1.7M1.28M1.89M1.62M1.55M1.49M1.71M1M945K871K840K867K1.5M
Other Income/Expense25.95M-31.8M20.74M11.72M20.42M3.43M16.49M13.1M10.29M-3.06M18.46M14M7.78M13.18M-426K594K1.4M-9.37M-1.14M1.47M
Pretax Income29.94M-187.56M-110.54M-104.31M-1.69M-104.67M-117.02M-30.25M3.11M-162.67M-20.83M-14.95M8.19M-55.94M-29.94M-20.46M655K-57.25M-36.74M-296.89M
Pretax Margin %2.11%-11.95%-7.7%-7.48%-0.11%-6.88%-8.07%-2.04%0.19%-19.95%-1.83%-1.4%0.78%-8.11%-4.31%-3.05%0.1%-12.37%-8.01%-59.5%
Income Tax-28K1.32M-331K62K196K1.76M-590K417K-133K267K1.21M1.07M-1.76M572K559K580K-71K179K256K435K
Effective Tax Rate %-0.09%-0.71%0.3%-0.06%-11.58%-1.68%0.5%-1.38%-4.27%-0.16%-5.81%-7.18%-21.47%-1.02%-1.87%-2.84%-10.84%-0.31%-0.7%-0.15%
Net Income29.97M-188.88M-110.21M-104.37M12.11M-105.79M-117.61M-30.68M-6.06M-230.43M-31.44M-16.75M16.02M-56.47M-30.67M-20.65M1.23M-56.72M-35.84M-298.85M
Net Margin %2.11%-12.03%-7.68%-7.48%0.79%-6.95%-8.11%-2.07%-0.38%-28.26%-2.77%-1.57%1.52%-8.19%-4.41%-3.08%0.19%-12.25%-7.82%-59.89%
Net Income Growth %147.46%-78.54%6.3%-240.17%299.74%54.09%-274.14%-83.19%-137.85%-308.09%-2.5%18.89%1202.6%0.45%14.44%93.09%108.16%-134.24%-203.06%-
Net Income (Continuing)29.97M-188.88M-110.21M-104.37M-1.89M-106.43M-116.43M-30.66M3.25M-162.93M-22.04M-16.03M9.95M-56.51M-30.5M-21.04M726K-57.43M-36.99M-297.33M
Discontinued Operations00001000K640K-1000K0-1000K-1000K-1000K-769K1000K-35K-236K307K429K689K1000K-1000K
Minority Interest0000000-768K-788K-818K-767K-720K-674K-611K-528K-457K-375K-300K-284K-169K
EPS (Diluted)1.80-11.50-6.75-6.250.75-6.50-7.25-1.75-0.25-14.00-2.00-1.001.00-3.50-1.75-1.250.07-3.50-2.25-19.75
EPS Growth %140%-76.92%6.9%-257.14%400%53.57%-262.5%-75%-125%-300%-14.29%20%1279.31%0%22.22%93.67%106.26%-105.28%-192.21%-
EPS (Basic)1.80-11.50-6.75-6.250.75-6.50-7.25-1.75-0.25-14.00-2.00-1.001.00-3.50-1.75-1.250.08-3.50-2.25-19.75
Diluted Shares Outstanding16.66M16.58M16.58M16.55M16.52M16.48M16.46M16.45M16.36M16.36M16.23M16.41M17.06M16.48M16.44M16.29M16.96M15.86M15.65M15.1M
Basic Shares Outstanding16.6M16.58M16.58M16.55M16.52M16.48M16.46M16.45M16.36M16.36M16.23M16.41M16.53M16.48M16.44M16.29M16.08M15.86M15.65M15.1M
Dividend Payout Ratio--------------------